This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Bright Peak Therapeutics Ag. Active years: 2023-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023-2026
Title: Claudia Fetz: Innovator in Modified IL-2 Polypeptides
Introduction
Claudia Fetz is a prominent inventor based in Basel, Switzerland. She has made significant contributions to the field of biotechnology, particularly in the development of modified IL-2 polypeptides. Her work focuses on innovative treatments for diseases, including cancer.
Latest Patents
Claudia Fetz holds 1 patent for her invention titled "Modified IL-2 polypeptides and uses thereof." This patent encompasses modified IL-2 polypeptides, compositions that include these polypeptides, and methods for their production and application. Notably, her research highlights the potential of these modified IL-2 polypeptides in cancer treatment, showcasing their preferential binding to the IL-2 receptor βγ complex over the IL-2 receptor αβγ complex. Additionally, the molecular weight distribution of these polypeptides is characterized as monodispersed.
Career Highlights
Claudia Fetz is associated with Bright Peak Therapeutics AG, where she continues to advance her research and development efforts. Her innovative approach has positioned her as a key figure in the biotechnology sector.
Collaborations
Claudia collaborates with esteemed colleagues, including Vijaya Raghavan Pattabiraman and Roberto Iacone, to further enhance the impact of her research.
Conclusion
Claudia Fetz's contributions to the field of modified IL-2 polypeptides represent a significant advancement in therapeutic options for cancer treatment. Her innovative work continues to inspire progress in biotechnology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile